Gerlach Rüdiger, Raabe Andreas, Scharrer Inge, Meixensberger Jürgen, Seifert Volker
Department of Neurosurgery, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.
Neurol Res. 2004 Jan;26(1):61-6. doi: 10.1179/016164104773026543.
Intracranial meningiomas are mainly benign lesions amenable for surgical resection. However, removal of an intracranial meningioma carries a higher risk of post-operative hemorrhage compared to surgery for other intracranial neoplasms. Because avoidance of post-operative hematoma is of vital interest for neurosurgical patients, the aim of this retrospective study was to analyze risk factors of post-operative hematoma associated with meningioma surgery. Two hundred and ninety six patients with intracranial meningiomas, operated between June 1998 and June 2002, were included in this study. Patients who developed a space-occupying post-operative intracranial hemorrhage and were treated surgically were identified. Data of patients with and without hematoma were retrospectively analyzed to identify risk factors associated with post-operative hematoma. Variables analyzed included patients' age, invasion of venous sinus by the meningioma, tumor vascularization, arachnoidal infiltration, pre-operative prophylaxis of thromboembolic events, peri-operative coagulation abnormalities, residual tumor, location and histology of the tumor. Outcome of patients with post-operative hematoma was assessed according to the Glasgow Outcome Scale (GOS) at discharge and at three months. 21 patients (7.1 %) of 296 patients developed a post-operative intracranial hematoma requiring surgical evacuation. Age was significantly higher in the hematoma group 62.4 +/- 14.0 years compared to patients without post-operative hematoma 56.1 +/- 12.0 (p < 0.05; t-test). Patients older than 70 years had a six-fold increased risk to develop a post-operative hematoma (Chi2 test, 95% CI 1.949-13.224). Patients with post-operative hemorrhage had significant lower post-operative prothrombin time, fibrinogen and platelets immediately after surgery and lower platelets at day 1. None of the other parameters, including pre-operative routine coagulation values, differed significantly between patients with and without post-operative hemorrhage. Three patients with post-operative hematoma showed platelet dysfunction and three patients showed decreased FXIII activity. Of those patients with post-operative hemorrhage at three months follow up three patients (13%) succumbed from reasons not directly related to hemorrhage, one patient remained GOS 2 (4.3%), four patients (17.4%) were GOS 3 and 15 (65.4%) patients had favorable outcome (GOS 4 [one patient] and GOS5 [14 patients]). Meningioma surgery carries a higher risk for post-operative hematoma in the elderly. Thrombocytopenia and other hemostatic disorders were frequently associated with post-operative hemorrhage after meningioma surgery, while no surgical factors could be defined. Extending coagulation tests and specific replacement therapy may prevent hematoma formation and improve the patients outcome.
颅内脑膜瘤主要是适合手术切除的良性病变。然而,与其他颅内肿瘤手术相比,切除颅内脑膜瘤术后出血风险更高。由于避免术后血肿对神经外科患者至关重要,本回顾性研究的目的是分析与脑膜瘤手术相关的术后血肿危险因素。本研究纳入了1998年6月至2002年6月期间接受手术的296例颅内脑膜瘤患者。识别出发生术后占位性颅内出血并接受手术治疗的患者。对有血肿和无血肿患者的数据进行回顾性分析,以确定与术后血肿相关的危险因素。分析的变量包括患者年龄、脑膜瘤侵犯静脉窦、肿瘤血管化、蛛网膜浸润、术前预防血栓栓塞事件、围手术期凝血异常、残留肿瘤、肿瘤位置和组织学。根据格拉斯哥预后量表(GOS)在出院时和三个月时评估术后血肿患者的预后。296例患者中有21例(7.1%)发生术后颅内血肿,需要手术清除。血肿组患者年龄明显高于无术后血肿患者,分别为62.4±14.0岁和56.1±12.0岁(p<0.05;t检验)。70岁以上患者发生术后血肿的风险增加了6倍(卡方检验,95%可信区间1.949 - 13.224)。术后出血患者术后立即的凝血酶原时间、纤维蛋白原和血小板明显较低,第1天时血小板也较低。包括术前常规凝血值在内的其他参数在有和无术后出血的患者之间没有显著差异。3例术后血肿患者出现血小板功能障碍,3例患者因子ⅩⅢ活性降低。在三个月随访时有术后出血的患者中,3例(13%)因与出血无直接关系的原因死亡,1例患者格拉斯哥预后量表评分为2分(4.3%),4例患者(17.4%)为3分,15例患者(65.4%)预后良好(1例患者为4分,14例患者为5分)。脑膜瘤手术在老年患者中术后血肿风险更高。血小板减少和其他止血障碍常与脑膜瘤手术后的术后出血相关,而未发现手术因素。延长凝血检测和特定替代治疗可能预防血肿形成并改善患者预后。